First-pass extracted concept

biomaterials

Candidate: concept label2 source documents2 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

Biomaterials are described as delivery-enabling therapeutic platforms in poststroke recovery.

Source 2DOI PubMed

What problem it solves

They are positioned as helping deliver agents that enhance or induce neuroplasticity.

Source 2DOI PubMed

Evidence Snippets

highlighting the three key elements: therapeutic genes, gene vectors, and biomaterials.

Evidence 1Source 1DOI PubMedprovenance

Nanomedicine, biomaterials, and biologically driven systems enable the precise delivery of agents, neurotrophic factors, and genetic modulators to enhance and induce plasticity.

Evidence 2Source 2DOI PubMedprovenance

Supporting Sources

Source 1primary paper2026MEDDOI PubMed

1 evidence snippet 1 linked claim Claim 1

Source 2primary paper2026MEDDOI PubMed

1 evidence snippet 1 linked claim Claim 1

Linked Claims

Claim 1frameworksupports2026Source 1DOI PubMed

The review frames biomaterial-assisted gene therapy for bone repair around three key elements: therapeutic genes, gene vectors, and biomaterials.

Quoted textsource-backed

the foundations of biomaterial-assisted gene therapy for bone repair are elucidated from a holistic perspective, highlighting the three key elements: therapeutic genes, gene vectors, and biomaterials.

Claim 2use casesupports2026Source 2DOI PubMed

Nanomedicine, biomaterials, and biologically driven systems enable precise delivery of agents, neurotrophic factors, and genetic modulators to enhance and induce poststroke plasticity.

Quoted textsource-backed

Nanomedicine, biomaterials, and biologically driven systems enable the precise delivery of agents, neurotrophic factors, and genetic modulators to enhance and induce plasticity.